Skip to main content
SpringerLink
Log in

Management of HIV-Related Bodyweight Loss

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Involuntary bodyweight loss is a frequent manifestation of HIV infection and ultimately affects the majority of patients. Because it portends a poor prognosis and adversely affects quality of life, nutritional intervention has an important role in the care of all HIV-infected persons. The mechanism of HIV-related bodyweight loss is multifactorial and includes complex interactions between decreased caloric intake, malabsorption and metabolic and/or hormonal abnormalities. Treatment of reversible and identifiable causes of bodyweight loss such as opportunistic infections and adverse effects of therapy are essential for the maintenance of bodyweight. For patients with anorexia of unclear aetiology, there are effective appetite stimulants available. Enteral and parenteral alimentation are under evaluation for their role in maintenance and/or repletion of bodyweight for patients with HIV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beal J, Olson R, Shepard KV. Effect of dronabinol on appetite and weight in AIDS: long-term follow-up. Abstract no. PO-B36-2345. Proceedings of the IXth International Conference on AIDS, Berlin, June, 1993

  • Bruera E, MacMillan K, Kuehn N, et al. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66: 1279–1282, 1990

    Article  PubMed  CAS  Google Scholar 

  • Chelluri L, Jastremski MS. Incidence of malnutrition in patients with acquired immunodeficiency syndrome. Nurtition in Clinical Practice 4: 16–18, 1989

    Article  CAS  Google Scholar 

  • Chlebowski RT, Grosvenor MB, Bernhard NH, et al. Nutritional status, gastrointestinal dysfunction and survival in patients with AIDS. American Journal of Gastroenterology 84:1288–1293, 1989

    PubMed  CAS  Google Scholar 

  • Cohan GR, Muurahainen N, Guenter P, et al. HIV related hospitalization, CD4 percent and nutritional markers. Abstract no. PUB 7113. Proceedings of the VIIIth International Conference on AIDS, Amsterdam, June, 1992

  • Cope FO, Hellerstein MK, Reese R, et al. Specific markers of immune function and nutrient interaction in the HIV+/AIDS patient; the effect of a peptide-based enteral formula. Proceedings of the IXth International Conference on AIDS, Berlin, June, 1993

  • Council of STate and Territorial Epidemiologists, AIDS Program, Centers for Infectious Disease, Centers for Disease Control. Revision of the CDC surveillence case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 36(Suppl. 1): 3S-15S, 1987

  • Flynn N, Enders S, Oster M, et al. Megestrol acetate 800 mg/day vs. placebo for treatment of weight loss and anorexia in AIDS patients. Abstract no. POB3687. Proceedings of the VIIIth International Conference on AIDS, Amsterdam, 1992

  • Gerard L, Flondre P, Leport C, et al. Determination of predictive markers in hospitalized patients with AIDS. Abstract no. PUB7202. Proceedings of the VIIIth International Conference on AIDS, Amsterdam, June 1992

  • Gorter R, Seefried M, Volberding P. Dronabinol effects on weight in patients with HIV infection. AIDS 6: 127–138, 1992

    Article  PubMed  CAS  Google Scholar 

  • Gottlieb MS, Groopman JE, Weinstein WM, et al. The acquired immunodeficiency syndrome. Annals of Internal Medicine 99: 208–220, 1983

    PubMed  CAS  Google Scholar 

  • Grunfeld C, Kotler DP. The wasting syndrome and nutritional support in AIDS. Seminars in Gastrointestinal Disease 2: 25–36, 1991

    Google Scholar 

  • Grunfeld C, Kotier DP, Shigenaga JK, et al. Circulating interferon alpha-levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. American Journal of Medicine 90: 154–162, 1991

    PubMed  CAS  Google Scholar 

  • Grunfeld C, Pang M, Shimizu L, et al. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. American Journal of Clinical Nutrition 55: 455–460, 1992

    PubMed  CAS  Google Scholar 

  • Hickey MS, Weaver KW. Nutritional management of patients with ARC or AIDS. Gastroenterology Clinics of North America 17: 545–561, 1988

    PubMed  CAS  Google Scholar 

  • Hommes MJT, Romijn JA, Godried MH, et al. Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism 39: 1186–1190, 1990

    Article  PubMed  CAS  Google Scholar 

  • Kotier DP, Tierney AR, Altillo D, et al. Body mass repletion during ganciclovir treatment of cytomegalovirus infections in patients with acquired immunodeficiency syndrome. Archives of Internal Medicine 149: 901–905, 1989a

    Article  Google Scholar 

  • Kotier DP, Tierney AR, Brenner SK, et al. Preservation of short-term energy balance in clinically stable AIDS patients. American Journal of Clinical Nutrition 51: 17–23, 1991

    Google Scholar 

  • Kotier DP, Tierney AR, Culpepper-Morgon JA, et al. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. Journal of Parenteral and Enteral Nutrition 14: 454–458, 1990

    Article  Google Scholar 

  • Kotier DP, Tierney AR, Wong J, Piersen Jr RN. Magnitude of body-cell mass depletion and the timing of death from wasting in AIDS. American Journal of Clinical Nutrition 50: 444–447, 1989b

    Google Scholar 

  • Lahdevirta J, Maury CPJ, Teppo A, et al. Elevated levels of circulating cachectic/TNF in patients with acquired immunodeficiency syndrome. American Journal of Medicine 85: 289–291, 1988

    Article  PubMed  CAS  Google Scholar 

  • Loprinizi CL, Ellison NM, Schard DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and ca-chexia. Journal of the National Cancer Institute 82: 1127–1132, 1990

    Article  Google Scholar 

  • McKinley MJ, Goodman-Block J, Salbe AD. Improved nutritional status as a result of nutrition intervention in adult HIV positive outpatients. Abstract no. PO-B36-2365. Proceedings of the IXth International Conference on AIDS, Berlin, June 1993

  • Melchior JC, Raguin G, Rigaud D, et al. Acute systemic infection predicted by unusual increase in energy expenditure in HIV-in-fected patients. Abstract no. W.B.2445. International Conference on AIDS 7: 193, 1991a

    Google Scholar 

  • Melchior JF, Salmon D, Rigaud P, et al. Increased energy expenditure and lean body mass in HIV infected patients. Abstract no. THB204. Vllth International Conference on AIDS, Florence, Italy, June 1991b

  • Nahlen BL, Chu SY, Nwahyahwu OG, et al. HIV wasting syndrome in the United States. AIDS 7: 183–188, 1993

    Article  PubMed  CAS  Google Scholar 

  • Nelson JA, Wiley CA, Reynolds-Kohler C, et al. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1: 259–262, 1988

    Article  PubMed  CAS  Google Scholar 

  • Palenicek JG, He D, Graham NMH, et al. Weight loss as a predictor of survival after AIDS among HIV-infected gay men enrolled in the MACS. Abstract no. WS-B34-1. Proceedings of the IXth International Conference on AIDS, Berlin, June, 1993

  • Richards EW, Hellerstein MK, Hoh R, et al. The effect of a peptide-based formula on specific markers of immune function in the HIV+/AIDS patient. Clinical Research 41: 124A, 1993a

    Google Scholar 

  • Richards EW, Hellerstein MK, Hoh R, et al. Maintenance of weight in the HIV+/AIDS patient: effect of a specialized peptide-based formula. Abstract no. PO-B36-2370. Proceedings of the IXth International Conference on AIDS, Berlin, June 1993b

  • Smith PD, Quin TC, Stoberwarren JEN, Masur H. Gastrointestinal infections in AIDS. Annals of Internal medicine 116: 63–77, 1992

    PubMed  CAS  Google Scholar 

  • Ullrich R, Zeitz M, Hise W, et al. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Annals of Internal Medicine 111: 15–21, 1989

    PubMed  CAS  Google Scholar 

  • Von Roenn J, Murphy RL, Weber KM, et al. Megestrol acetate for the treatment of cachexia associated with human immunodeficiency virus (HIV) infection. Annals of Internal Medicine 109: 840–841, 1988

    Google Scholar 

  • Von Roenn J, Armstrong D, Dickmeyer MS, Kotier DP, et al. megestrol acetate in patients with AIDS-related cachexia. Annals of Internal Medicine, in press, 1994

Download references

Author information

Authors and Affiliations

  1. Northwestern University Medical School, 233 E. Erie, Suite 700, Chicago, Illinois, IL 60611, USA

    Jamie H. Von Roenn

Authors
  1. Jamie H. Von Roenn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Von Roenn, J.H. Management of HIV-Related Bodyweight Loss. Drugs 47, 774–783 (1994). https://doi.org/10.2165/00003495-199447050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199447050-00005

Keywords

Search

Navigation